| 
		From cruise liners to supply chains, China virus hurts
		 Send a link to a friend 
		
		 [February 06, 2020] 
		By David Stanway and Roxanne Liu 
 SHANGHAI/BEIJING (Reuters) - China's 
		fast-moving coronavirus spread among passengers of a quarantined 
		Japanese cruise liner on Thursday and dragged down production at more 
		global businesses, as scientists across the world searched for a 
		vaccine.
 
 The death toll from the virus in mainland China jumped by 73 to 563, 
		with more than 28,000 confirmed infections inside the workshop of the 
		world and its second-largest economy.
 
 Moored off Japan, about 3,700 people on Carnival's Diamond Princess face 
		testing and quarantine for at least two weeks on the ship, which has 20 
		virus cases.
 
 Japan now has 45 virus cases.
 
 Gay Courter, a 75-year-old American novelist on board, said he hoped the 
		U.S. government would take the Americans off.
 
 "It’s better for us to travel while healthy and also, if we get sick, to 
		be treated in American hospitals," he told Reuters.
 
 In Hong Kong, another cruise ship with 3,600 passengers and crew was 
		quarantined for a second day pending testing after three cases on board.
 
 Taiwan, which has 13 cases, banned international cruise ships from 
		docking.
 
		
		 
		
 In China, cities have been shut off, flights cancelled and factories 
		closed, shutting supply lines crucial to the world economy. Companies 
		including Hyundai Motor <005380.KS>, Tesla <TSLA.O>, Ford <F.N>, PSA 
		Peugeot Citroen <PEUP.PA>, Nissan <7201.T>, Airbus <AIR.PA>, Adidas <ADSGn.DE> 
		and Foxconn <2317.TW> are taking hits.
 
 Financial analysts have cut China's growth outlook, with ratings agency 
		Moody's signalling risks for auto sales and output.
 
 Nintendo Co Ltd <7974.T> said on Thursday delays to production and 
		shipping of its Switch console and other goods to the Japan market were 
		"unavoidable" due to the coronavirus.
 
 Honda Motor Co <7267.T> was considering keeping operations suspended for 
		longer than planned at its three plants in Wuhan, the epicentre of the 
		virus, Japan's Nikkei newspaper reported.
 
 Indonesia said it stands to lose $4 billion in earnings from tourism if 
		travel from China is disrupted for the whole year.
 
 Chinese-ruled Hong Kong, hit by months of sometimes violent anti-China, 
		pro-democracy unrest, said the coronavirus was hurting its economy and 
		urged banks to adopt a "sympathetic stance" with borrowers.
 
 But global stocks extended their recovery, cheered by record closes on 
		Wall Street and China's announcement of a tariff cut on some imports 
		from the United States, which analysts saw as a move to boost 
		confidence.
 
 China, which has bristled at being ostracised over the virus, was 
		considering delaying an annual meeting of its highest legislative body, 
		the National People's Congress, from March 5, sources said.
 
 "The situation doesn't look likely to be contained by March," a 
		government official told Reuters.
 
		RUSH FOR HIV DRUG
 Several countries, including the United States, have banned entry to 
		visitors who have been in China over the previous two weeks.
 
 News of another virus hot spot emerged, linked to a mid-January company 
		meeting in Singapore. At least three people caught the disease after a 
		conference held with 94 overseas staff, including one from Wuhan.
 
 [to top of second column]
 | 
            
			 
            
			Passengers wearing face masks look out from a cabin on the World 
			Dream cruise ship, after it had been denied entry in Taiwan amid 
			concerns of coronavirus infection on board, at the Kai Tak Cruise 
			Terminal in Hong Kong, China February 6, 2020. REUTERS/Tyrone Siu 
            
 
            Authorities have not identified the company, but the World Health 
			Organization (WHO) said it was investigating.
 Singapore has reported 28 infections, some involving 
			person-to-person transmission.
 
 Health officials in the United States and China want to get a 
			vaccine to initial human testing within months, but drugmakers have 
			cautioned they have a long way to go.
 
 "There are no known effective therapeutics," WHO spokesman Tarik 
			Jasarevic said, when asked about reports of "breakthroughs" that 
			boosted markets on Wednesday.
 
 China's National Health Commision said the HIV drug lopinavir/ritonavir 
			could be used for coronavirus patients, without specifying how.
 
 That triggered a rush, specifically for Kaletra, also known as 
			Aluvia, which is drugmaker AbbVie's <ABBV.N> off-patent version of 
			lopinavir/ritonavir and the only version approved for sale in China.
 
 Devy, a 38-year-old freelancer in Shandong province, said he was 
			among hundreds who had contacted people with HIV to ask for 
			medicine.
 
 "When you are left alone, seeing the blur shadow of death far away, 
			I think no one can feel calm," Devy told Reuters.
 
 Hundreds of experts will gather in Geneva on Feb. 11-12 to try to 
			speed research into drugs and vaccines, the WHO said, adding that a 
			multinational WHO-led team would also visit China.
 
 National officials said 3,694 cases were reported throughout China 
			on Wednesday, the first day in more than a week to see a fall in new 
			daily cases.
 
 Two deaths outside mainland China, in the Philippines and Hong Kong, 
			have both involved visits to Wuhan, where more than 400 people have 
			died.
 
            
			 
			Nearly 260 cases have been reported in 31 countries and regions 
			outside mainland China, according to a Reuters tally.
 More than two dozen airlines have suspended or restricted flights to 
			China and hundreds of foreigners have been evacuated from Wuhan and 
			placed in quarantine.
 
 The virus is also stirring animosity in the decades-old dispute 
			between self-ruled Taiwan and China, with the island complaining 
			that China is providing the WHO with wrong information about its 
			cases.
 
 (Reporting by Lusha Zhang, Ryan Woo, Roxanne Liu, Liangping Gao and 
			Se Young Lee in Beijing; David Stanway, Yilei Sun and Winni Zhou in 
			Shanghai; Alun John and Noah Sin in Hong Kong; Ju-min Park in Tokyo; 
			Stephanie Nebehay in Geneva; Kate Kelland in London; Writing by 
			Robert Birsel and Nick Macfie; Editing by Andrew Cawthorne)
 
			[© 2020 Thomson Reuters. All rights 
				reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |